(Q36225416)

12 August 2017

Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection (English)

1 reference

12 August 2017

0 references

R A M Breen

1

1 reference

12 August 2017

R F Miller

2

1 reference

12 August 2017

T Gorsuch

3

1 reference

12 August 2017

C J Smith

4

1 reference

12 August 2017

A Schwenk

5

1 reference

12 August 2017

W Holmes

6

1 reference

12 August 2017

J Ballinger

7

1 reference

12 August 2017

L Swaden

8

1 reference

12 August 2017

M A Johnson

9

1 reference

12 August 2017

I Cropley

10

1 reference

12 August 2017

M C I Lipman

11

1 reference

12 August 2017

language of work or name

English

0 references

publication date

14 July 2006

1 reference

12 August 2017

1 reference

12 August 2017

61

1 reference

12 August 2017

9

1 reference

12 August 2017

791-794

1 reference

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Liver injury during antituberculosis treatment: an 11-year study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117099

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16844730

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of Standard Therapy for Tuberculosis is Associated with Increased Adverse Reactions in Patients with HIV

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16844730

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.2006.058867

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

16844730

1 reference